Zvast Biotechnology
Jiangxi Zvast-Biotechnology Co., Ltd. is a high-tech enterprise with the core business of researching and developing human disease animal models (animal modeling). The company has successfully developed 600 human disease animal models, which are used to provide research objects and platforms for CRO drug efficacy screening, drug metabolism, non-GLP safety evaluation, life science experiments, and the transformation of medical science and technology achievements.
As life sciences and medical research enter new fields, the demand for animal models is increasing. Animal models are important experimental resources in the development of new drugs. In particular, research on major infectious diseases and complex human diseases requires stable and effective disease animal models as support. The company has established an experimental base of 20,000 square meters, including an animal center, a cell center, a nucleic acid protein laboratory, a pathology laboratory, a molecular laboratory, a microbiology laboratory, and a biological material laboratory, covering the Skin Disease, Respiratory System, Locomotor System, Digestive System, Immune system, Pain Disease, Reproductive System, Metabolic System, Neuroscience, Cardiovascular System, Otolaryngology, Head, and Neck Science, Oral and Maxillofacial Science, Eye Disease, Urinary System, Transplantation Model, CDX. A stable technical barrier is formed at the rate of developing nearly 100 new models every year.
Founded
Focus on Disease Models
Annual revenue 20+ million RMB
Invested 10 + million RMB in software and hardware
National High-Tech Enterprise
Officially enter the CRO field
Moved into 20,000 ㎡ New Site
600+ Disease Models
AAALAC & ISO
Founded
Focus on Disease Models
Annual revenue 20+ million RMB
Invested 10 + million RMB in software and hardware
National High-Tech Enterprise
Officially enter the CRO field
Moved into 20,000 ㎡ New Site
600+ Disease Models
AAALAC & ISO
Zvast Biotechnology pharmacology platform and team possess extensive professional expertise and experience. After years of accumulated experience, they have supported dozens of client pharmacology and efficacy project submissions. The team has progressively built and refined a library of tumor and non-tumor cell and animal models, providing various effective efficacy models according to client needs to deliver pharmacology and efficacy services. The platform has established a rich collection of CDX models, as well as various non-tumor disease animal models. It can support a wide range of drug types, including small molecule compounds, peptides, antibody drugs (monoclonal antibodies, bispecific/multispecific antibodies, nanobodies, etc.), CGT products (immune cell therapy products, stem cell therapy products, etc.), and nucleic acid drugs. The constructed animal species include non-human primates, mice and rats of various sizes, rabbits, guinea pigs, pigs, dogs, and sheep.
VIEW MORE
Over 600 animal models for various diseases, with more than 100 models including positive drug controls, and our original models possess high translational value.
SPF-grade laboratory + Class 100,000 clean environment, with strict SOP/QA management to ensure experimental quality
Over 300 projects have been exhibited, accumulating rich experience in pharmacological and efficacy projects
The laboratory is equipped with various functions, enabling independent model construction and data analysis
Our promise is to resolve: resolve your challenges with exceptional solutions; resolve your scientific needs through our deep knowledge and agility; resolve your projects with an open mindset and seamless communication.
At Zvast-Bio, our vision is to advance global life science with exceptional models and services.
We provide one-stop drug efficacy animal model services aimed at accelerating translational studies of life science and medicine.
Our mission is to create infinite possibilities for biomedical research by providing reliable service, scalable technologies, and expert guidance.
